Manama: The National Health Regulatory Authority (NHRA) has announced the withdrawal and suspension of registration of the pharmaceutical product “PROTON 40mg E.C TABLET – PROTON 20mg E.C TABLET”, produced by the Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO). The move is based on the warning issued by the Saudi Food and Drug Authority (SFDA) on March 12, 2021. The NHRA indicated said that it has withdrawn the medicine from the Kingdom, and suspended its registration because it does not match the original product. The NHRA recommended the health authorities to withdraw the product as soon as it is available to them, calling on the medicine users to contact their doctors to receive the alternative medication.
Trending
- Foreign Ministry continues efforts to facilitate return of Bahraini citizens from abroad
- Saudi Royal Court announces Friday first day of Eid Al Fitr
- GCC launches logistics fast track route to facilitate movement of goods
- Gulf Air adds Paris and Manila to temporary network via Dammam
- Qatar reports missile attack on Ras Laffan Industrial City causing material damage
- Kuwait: Two paramedics injured by shrapnel, conditions stable
- CBB 12 Month Treasury Bills Issue 138 Fully subscribed
- UAE air defences engage 10 ballistic missiles, 45 UAVs
